PharmTech Drug Digest 11.20
News|Articles|November 20, 2014

Vetter Opens New Office in Singapore to Support Growing Asian Market

CDMO Vetter has opened a new representative office in Singapore in response to growing market demand in Asia.

CDMO Vetter, a specialist in aseptic fill and finish of injection systems for the bio/pharmaceutical industry, has opened a new representative office in Singapore in response to growing market demand in Asia. The announcement was made at a ceremony attended by members of local government agencies, a number of executives of pharmaceutical/biotech companies in the Asian region, and Vetter executives.

The new office, headed by Chervee Ho, director, Key Account Management, Asia Pacific, will enable the company to better serve the Asian market, which was previously handled by Vetter’s German-based departments.

Source: Vetter-Pharma


Related to this article

white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.